| 1 | [SID49819194] | Active | AC50 | 5.31 | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_CherryPick_Activity [AID588683, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | AC50 | 5.31 [uM] | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588683 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 2 | [SID49819194] | Active | AC50 | 5.31 | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_CherryPick_Activity [AID588683, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | AC50 | 5.31 [uM] | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588683 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 3 | [SID49819194] | Active | AC50 | 7.641 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | AC50 | 7.641 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 4 | [SID49819194] | Active | AC50 | 8.041 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | AC50 | 8.041 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 5 | [SID49819194] | Active | Potency | 18.3374 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | Potency | 18.3374 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 6 | [SID49819194] | Active | Potency | 18.3374 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | Potency | 18.3374 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 7 | [SID49819194] | Active | EC50 | 18.6 | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex [AID602473, Type: confirmatory] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | EC50 | 18.6 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 602473 | | BioAssay type | confirmatory | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 8 | [SID49819194] | Active | EC50 | 18.6 | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex [AID602473, Type: confirmatory] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | EC50 | 18.6 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 602473 | | BioAssay type | confirmatory | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 9 | [SID49819194] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 10 | [SID49819194] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 11 | [SID49819194] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 12 | [SID49819194] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 13 | [SID49819194] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 14 | [SID49819194] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 15 | [SID49819194] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 16 | [SID49819194] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 17 | [SID49819194] | Active | IC50 | | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 18 | [SID49819194] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 19 | [SID49819194] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 20 | [SID49819194] | Active | | | Luminescence Microorganism Retest to Identify Inhibitors of the AI-2 Quorum Sensing System [AID2727, Type: screening] | Alkanal monooxygenase alpha chain [gi:126509] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Luminescence Microorganism Retest to Identify Inhibitors of the AI-2 Quorum Sensing System | | AID | 2727 | | BioAssay type | screening | | Target | Alkanal monooxygenase alpha chain [gi:126509] | | PubMed | | | Data Table |  |
|
| 21 | [SID49819194] | Active | | | Luminescence Microorganism-Based Retest to Identify Modulators of the AI-2 Quorum Sensing System [AID2736, Type: screening] | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Luminescence Microorganism-Based Retest to Identify Modulators of the AI-2 Quorum Sensing System | | AID | 2736 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] | | PubMed | | | Data Table |  |
|
| 22 | [SID49819194] | Active | | | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System [AID2094, Type: screening] | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System | | AID | 2094 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The Apo Form Of Vibrio Harveyi Luxp Complexed With The Periplasmic Dom [gi:67463988] | | PubMed | | | Data Table |  |
|
| 23 | [SID49819194] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 24 | [SID49819194] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 25 | [SID49819194] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 26 | [SID49819194] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 27 | [SID49819194] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 28 | [SID49819194] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 29 | [SID49819194] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602230, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602230 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 30 | [SID49819194] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 31 | [SID49819194] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 32 | [SID49819194] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 33 | [SID49819194] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 34 | [SID49819194] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 35 | [SID49819194] | Active | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Active | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 36 | [SID49819194] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID49819194] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 38 | [SID49819194] | Inactive | Potency | 14.1254 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 39 | [SID49819194] | Inactive | Potency | 14.1254 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 40 | [SID49819194] | Inactive | Max_Activity_Concentration_uM | 50 | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity [AID651823, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Max_Activity_Concentration_uM | 50 [uM] | | BioAssay | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity | | AID | 651823 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 41 | [SID49819194] | Inactive | Max_Activity_Concentration_uM | 50 | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity [AID651823, Type: confirmatory] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Max_Activity_Concentration_uM | 50 [uM] | | BioAssay | Thermal shift assay to identify compound binding to Kelch domain of Keap1 protein Measured in Biochemical System Using RT-PCR - 2119-02_Inhibitor_Dose_CherryPick_Activity | | AID | 651823 | | BioAssay type | confirmatory | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 42 | [SID49819194] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 43 | [SID49819194] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 44 | [SID49819194] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 45 | [SID49819194] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 46 | [SID49819194] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 47 | [SID49819194] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 48 | [SID49819194] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 49 | [SID49819194] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 50 | [SID49819194] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49819194 | | CID | 24817800 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|